Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(5;17)(q33-34;q11.2) PDGFRB/MYO18A

Written2018-01Jean-Loup Huret, Philippe Dessen

(Note : for Links provided by Atlas : click)

Identity

ICD-Topo C420,C421,C424 BLOOD, BONE MARROW, & HEMATOPOIETIC SYS
Atlas_Id 1571

Clinics and Pathology

Disease -

Genes involved and Proteins

Gene NamePDGFRB
Location 5q32
Gene NameMYO18A
Location 17q11.2

To be noted

Non-annotated chromosomal abnormality. Preliminary data : if you are an author who wish to write a full paper/card on the chromosome abnormality, go to  How to contribute

Bibliography

Multiple MYO18A-PDGFRB fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11)
Sheng G, Zeng Z, Pan J, Kou L, Wang Q, Yao H, Wen L, Ma L, Wu D, Qiu H, Chen S
Mol Cytogenet 2017 Feb 27;10:4
PMID 28261327
 
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11
Walz C, Haferlach C, Hänel A, Metzgeroth G, Erben P, Gosenca D, Hochhaus A, Cross NC, Reiter A
2) Genes Chromosomes Cancer
PMID 19006078
 


Translocations implicated (Data extracted from papers in the Atlas)

 t(5;17)(q33-34;q11.2) PDGFRB/MYO18A

External links

PDGFRB (5q32) MYO18A (17q11.2)

Mitelman databaset(5;17)(q33-34;q11.2) [Case List]    t(5;17)(q33-34;q11.2) [Transloc-MCList] PDGFRB/MYO18A [Fusion-MCList]
COSMICHisto = - Site = haematopoietic_and_lymphoid_tissue (COSMIC)
arrayMap (UZH-SIB Zurich)[select an item]
 
 
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed
All articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jan 10 17:21:31 CET 2018


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.